David Adam, PhD
David Adam is a journalist and best-selling author. In 2014 he published The Man Who Couldn’t Stop, a book that discussed his own experiences of OCD, as well as discussing the science, history and treatments of the disorder. He has since been invited to speak on the topic around the world. His second book, The Genius Within, on the subject of intelligence and cognitive enhancement was published in 2018.
David is an editor at the science journal Nature and was previously a special correspondent at the Guardian, writing on science and the environment.
Susanne Ahmari, MD, PhD
Dr. Susanne Ahmari is assistant professor of Psychiatry at University of Pittsburgh, and Director of the Translational OCD Laboratory. Dr. Ahmari’s research program integrates basic neuroscience approaches and cutting-edge technology in animal models with clinical and post-mortem studies of OCD patients. Her ultimate goal is to identify molecular, cellular, and circuit-level changes that underlie the onset and persistence of abnormal repetitive and compulsive behaviors, and use this information to develop neuroscientifically-based treatments for OCD and other related disorders.
Sabine Bahn, MD, PhD, MRCPsych
Dr. Sabine Bahn is a practising psychiatrist, Chair in Neurotechnology and Director of the Cambridge Centre for Neuropsychiatric Research at Cambridge University. Her main research interests are to understand the molecular basis of neuropsychiatric disorders and develop novel diagnostics and therapeutics for psychiatric disorders, with a focus on schizophrenia and mood disorders. Sabine has published over 200 research articles and has co-founded 2 spin-out companies. Since 2015, Sabine has been a fellow of the Royal Society of Biology. She is also fellow of Lucy Cavendish College, Cambridge.
Lynne Drummond, MBChB, MRCP, FRCPsych
Lynne Drummond has been a Consultant Psychiatrist with South West London and St George’s NHS Mental Health Trust since 1985 where she has run a service specialising in CBT in combination with other treatments. Her research interests include OCD, anxiety disorders, CBT, the role exercise plays in mental health and the education of health care professionals. Lynne’s latest book is “Obsessive-Compulsive Disorders: All you want to know about OCD for those living with OCD, carers and clinicians”.
She is on the Board of Directors of the International College for Obsessive Compulsive Spectrum Disorders and Chairs the Obsessive Compulsive and related Disorders network at the Royal College of Psychiatrists.
Jim Hagan, PhD
Dr. Jim Hagan is a Senior Research Fellow in Neurosciences at Sosei-Heptares, working on drug discovery programmes for neuropsychiatric indications. Previously, he was the CEO at GMEC, a not-for-profit company formed by the Universities of Oxford and Cambridge, Imperial College, UCL, King’s College London and Queen Mary College London to foster biomedical translational research. He was Vice President and Head of Biology in the Psychiatry Centre of Excellence in Drug Discovery at GSK.
Stuart Montgomery, MD
Stuart Montgomery is emeritus professor of Psychiatry at Imperial College London. He is a past President of the European College of Neuropsychopharmacology (ECNP) and of the British Association of Psychopharmacology (BAP). His research in OCD has been seminal, as were his efforts in establishing educational charities in OCD. His rating scale in depression, the MADRS, is regarded as the most sensitive instrument and is widely used. He was a founding editor of European Neuropsychopharmacology and has edited International Clinical Psychopharmacology for 25 years.
Carolyn Rodriguez, MD, PhD
Dr. Carolyn Rodriguez is assistant professor in the Department of Psychiatry and Behavioural Science at Stanford University, School of Medicine. She utilises her training as a psychiatrist, neuroscientist, and clinical researcher to innovate rapid-acting treatments to relieve the suffering of patients with severe mental illnesses, including Obsessive-Compulsive Disorder.
Trevor Robbins, CBE, FRS, FMedSc
Prof Trevor Robbins is a professor of cognitive neuroscience with an international reputation in the fields of cognitive neuroscience, behavioural neuroscience and psychopharmacology. He is Director of the University of Cambridge’s Behavioural and Clinical Neuroscience Institute (BCNI) and is leading a multi-million-pound research study into the neuroscience of OCD.